We are live on ! Find out more
OLMA icon

Olema Pharmaceuticals
OLMA

87 hedge funds and large institutions have $329M invested in Olema Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 21 increasing their positions, 23 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

181% more capital invested

Capital invested by funds: $117M → $329M (+$212M)

169% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 13

34% more funds holding

Funds holding: 65 → 87 (+22)

33% more call options, than puts

Call options by funds: $370K | Put options by funds: $278K

7.09% more ownership

Funds ownership: 82.24% → 89.34% (+7.1%)

9% less repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 23

Holders
87
Holders Change
+22
Holders Change %
+33.85%
% of All Funds
1.37%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.03%
New
35
Increased
21
Reduced
23
Closed
13
Calls
$370K
Puts
$278K
Net Calls
+$92K
Net Calls Change
+$49K

Top Buyers

Rank Fund Capital Flow
1
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$8.39M
2
PBA
Paradigm Biocapital Advisors
New York
+$8.14M
3
BlackRock
BlackRock
New York
+$8.07M
4
WP
Woodline Partners
California
+$3.55M
5
MB
MPM BioImpact
Massachusetts
+$2.79M

Top Sellers

Rank Fund Capital Flow
1
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$7.28M
2
KCM
Kynam Capital Management
New Jersey
-$4.27M
3
Citadel Advisors
Citadel Advisors
Florida
-$3.59M
4
VC
Vivo Capital
California
-$2.11M
5
SAM
Sectoral Asset Management
Quebec, Canada
-$2.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
Two Sigma Advisers
26
Two Sigma Advisers
New York
$2.18M +$211K +35,000 +17%
Adage Capital Partners
27
Adage Capital Partners
Massachusetts
$2.09M -$1.14M -188,567 -45%
Ameriprise
28
Ameriprise
Minnesota
$2.07M +$1.38M +229,365 New
Vontobel Holding
29
Vontobel Holding
Switzerland
$2.07M -$656K -108,690 -32%
NM
30
Newtyn Management
New York
$1.58M -$1.21M -200,000 -53%
EI
31
EAM Investors
California
$1.53M +$1.02M +169,730 New
Two Sigma Investments
32
Two Sigma Investments
New York
$1.24M -$143K -23,729 -15%
PAMP
33
Polar Asset Management Partners
Ontario, Canada
$1.21M +$812K +134,500 New
SSA
34
Schonfeld Strategic Advisors
New York
$1.13M +$758K +125,612 New
BCM
35
Bridgeway Capital Management
Texas
$1.04M – – –
JGC
36
J. Goldman & Co
New York
$979K -$2.04M -338,693 -76%
ACP
37
Acuta Capital Partners
California
$956K +$639K +105,814 New
GCP
38
GSA Capital Partners
United Kingdom
$920K -$778K -128,792 -56%
N
39
Nuveen
North Carolina
$907K +$606K +100,450 New
Bank of New York Mellon
40
Bank of New York Mellon
New York
$825K +$478K +79,149 +649%
DCM
41
Driehaus Capital Management
Illinois
$782K +$523K +86,625 New
Charles Schwab
42
Charles Schwab
California
$722K +$371K +61,372 +330%
Jacobs Levy Equity Management
43
Jacobs Levy Equity Management
New Jersey
$677K -$940K -155,649 -68%
Morgan Stanley
44
Morgan Stanley
New York
$568K -$308K -51,033 -45%
Wellington Management Group
45
Wellington Management Group
Massachusetts
$552K +$369K +61,110 New
T. Rowe Price Associates
46
T. Rowe Price Associates
Maryland
$550K +$15.4K +2,553 +4%
AG
47
Algert Global
California
$525K +$276K +45,640 +367%
CAM
48
ClariVest Asset Management
California
$481K +$321K +53,200 New
EWA
49
EP Wealth Advisors
California
$418K +$2.77K +459 +10%
PFCS
50
Pale Fire Capital SE
Czech Republic
$397K +$266K +44,000 New
1
2
3 4

OLMA Hedge Fund Activity: Q2 2023 in Review

87 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Olema Pharmaceuticals (OLMA) for Q2 2023, worth a combined $329M — up 181% from $117M a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new OLMA positions and 13 closed out — a net gain of 22 holders — while 21 added to existing stakes and 23 trimmed.

The largest buyer was Dimensional Fund Advisors, adding an estimated $8.39M. The largest seller was Janus Henderson Group, exiting entirely with an estimated $7.28M sold.

  • 87 institutional investors held Olema Pharmaceuticals (OLMA) as of Q2 2023, up from 65 in Q1 2023.
  • Funds reported $329M of Olema Pharmaceuticals stock for Q2 2023, up 181% quarter-over-quarter.
  • 35 funds opened new Olema Pharmaceuticals positions in Q2 2023 and 13 closed out, a net change of +22 holders.
  • The largest Olema Pharmaceuticals buyer in Q2 2023 was Dimensional Fund Advisors, an estimated $8.39M added.
  • The largest Olema Pharmaceuticals seller in Q2 2023 was Janus Henderson Group, an estimated $7.28M sold.

Based on aggregated 13F filings for Q2 2023.